tiprankstipranks
Trending News
More News >
BioMark Diagnostics (TSE:BUX)
:BUX
Canadian Market

BioMark Diagnostics (BUX) Financial Statements

Compare
3 Followers

BioMark Diagnostics Financial Overview

BioMark Diagnostics's market cap is currently C$49.39M. The company's EPS TTM is C$-0.005; its P/E ratio is -29.94; BioMark Diagnostics is scheduled to report earnings on November 29, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 24Dec 22Dec 21Dec 20
Income Statement
Total RevenueC$ 154.22KC$ 163.22KC$ 153.49KC$ 43.93KC$ 0.00
Gross ProfitC$ 154.22KC$ 163.22KC$ -232.70KC$ 43.93KC$ -13.69K
Operating IncomeC$ -1.91MC$ -1.32MC$ -1.84MC$ -1.28MC$ -1.09M
EBITDAC$ -1.46MC$ -919.05KC$ -1.35MC$ -1.22MC$ -1.08M
Net IncomeC$ -1.93MC$ -1.43MC$ -1.84MC$ -1.45MC$ -1.09M
Balance Sheet
Cash & Short-Term InvestmentsC$ 2.48MC$ 156.75KC$ 72.04KC$ 382.71KC$ 877.68K
Total AssetsC$ 3.13MC$ 1.09MC$ 732.29KC$ 1.47MC$ 952.94K
Total DebtC$ 454.16KC$ 1.55MC$ 823.87KC$ 1.05MC$ 119.32K
Net DebtC$ -2.03MC$ 1.39MC$ 751.83KC$ 666.69KC$ -758.35K
Total LiabilitiesC$ 1.39MC$ 1.70MC$ 1.88MC$ 2.11MC$ 1.03M
Stockholders' EquityC$ 1.74MC$ -609.61KC$ -1.15MC$ -635.69KC$ -79.09K
Cash Flow
Free Cash FlowC$ -1.10MC$ -986.91KC$ -919.72KC$ -1.26MC$ -455.55K
Operating Cash FlowC$ -1.09MC$ -982.52KC$ -914.42KC$ -1.20MC$ -455.55K
Investing Cash FlowC$ -3.53KC$ -4.39KC$ -5.30KC$ -59.20KC$ -3.20K
Financing Cash FlowC$ 3.42MC$ 1.07MC$ 609.05KC$ 768.16KC$ 724.63K
Currency in CAD

BioMark Diagnostics Earnings and Revenue History

BioMark Diagnostics Debt to Assets

BioMark Diagnostics Cash Flow

BioMark Diagnostics Forecast EPS vs Actual EPS